OMB APPROVAL

OMB Number: 3235-0145
Expires:  October 31, 1994
Estimated average burden
hours per form 14.90

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. *)

MedPartners, Inc.
(Name of Issuer)

Common Stock
(Title of Class of Securities)

- -----------------------------------------------------------------
58503X107
(CUSIP Number)

Check the following box if a fee is being paid with the statement  
/  /.  (A fee is not required only if the reporting person:  (1) 
has a previous statement on file reporting beneficial ownership 
of more than five percent of the class of securities described in 
Item 1; and (2) has filed no amendment subsequent thereto 
reporting beneficial ownership of five percent or less of such 
class.)  (See Rule 13d-7.)

*The remainder of this cover page shall be filled out for a 
reporting person's initial filing on this form with respect to 
the subject class of securities, and for any subsequent amendment 
containing information which would alter disclosures provided in 
a prior cover page.

The information required on the remainder of this cover page 
shall not be deemed to be "filed" for the purpose of Section 18 
of the Securities Exchange Act of 1934 ("Act") or otherwise 
subject to the liabilities of that section of the Act but shall 
be subject to all other provisions of the Act (however, see the 
Notes).

SEC 1746 (2-92



SCHEDULE 13G
Page 2 of 5 Pages
CUSIP No. 58503X107

- -----------------------------------------------------------------
1	NAME OF REPORTING PERSON
	SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON

	Jurika & Voyles, L.P.
	IRS No.:  04-3330073
- -----------------------------------------------------------------
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)/  /  
(b)/  / 
- -----------------------------------------------------------------
3	SEC USE ONLY
- -----------------------------------------------------------------
4	CITIZENSHIP OR PLACE OF ORGANIZATION
	Delaware
- -----------------------------------------------------------------
NUMBER OF 		5	SOLE VOTING POWER
SHARES				-0-
BENEFICIALLY		-------------------------------------------
OWNED BY		6	SHARED VOTING POWER
EACH				      4,476,393    
REPORTING			-------------------------------------------
PERSON		7	SOLE DISPOSITIVE POWER
WITH					-0-
				-------------------------------------------
			8	SHARED DISPOSITIVE POWER
				      4,892,224     
- -----------------------------------------------------------------
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING 
	PERSON
	4,892,224 shares
- -----------------------------------------------------------------
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9)
	EXCLUDES CERTAIN SHARES* /  /
- -----------------------------------------------------------------
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
      3.09%
- -----------------------------------------------------------------
12	TYPE OF REPORTING PERSON*
	IA
- -----------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT



SCHEDULE 13G
Page 3 of 5 Pages
CUSIP No. 58503X107

ITEM 1.

	(a)	The name of the issuer is MedPartners, Inc.

	(b)	The principal executive office of MedPartners, Inc. is 
3000 Galleria Tower, Suite 1000, Birmingham, Alabama  35244.

ITEM 2.

	(a)	The name of the person filing this statement is Jurika 
& Voyles, L.P.

	(b)	The principal business office of Jurika & Voyles, L.P. 
is located at 1999 Harrison Street, Suite 700, Oakland, CA  
94612.

	(c)	Jurika & Voyles, L.P. is a Delaware limited 
partnership.

	(d)	This statement relates to shares of common stock of 
MedPartners, Inc. ("the Stock").

	(e)	The CUSIP number of the stock is 58503X107.

ITEM 3.  IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 
13D-2(B), CHECK WHETHER THE PERSON FILING IS A:

	(a)	/   /  Broker or Dealer registered under Section 15 of 
the Act.

	(b)	/   /  Bank as defined in section 3(a)(6) of the Act.

	(c)	/   /  Insurance Company as defined in section 
3(a)(19) of the Act.

	(d)	/   /  Investment Company registered under section 8 
of the Investment Company Act.

	(e)	/ X /  Investment Adviser registered under section 203 
of the Investment Advisers Act of 1940.

	(f)	/   /  Employee Benefit Plan, Pension Fund which is 
subject to the provisions of the Employee Retirement Income 



SCHEDULE 13G
Page 4 of 5 Pages
CUSIP No. 58503X107

Security Act of 1974 or Endowment Fund; see section 240.13d-
1(b)(1)(ii)(F).

	(g)	/   /  Parent Holding Company , in accordance with 
section 240.13d-1(b)(1)(ii)(F).

	(h)	/   /  Group, in accordance with section 240.13d-
1(b)(1)(ii)(H).

ITEM 4.  OWNERSHIP

	(a)	Jurika & Voyles, L.P. beneficially owns 4,892,224 
shares of the Stock.

	(b)	Jurika & Voyles, L.P. beneficially owns 3.09% of the 
Stock outstanding.

	(c)	(i)	Jurika & Voyles, L.P. has the sole power to vote 
or to direct the vote of -0- shares of the Stock.

	(d)	(ii)	Jurika & Voyles, L.P. has the shared power to 
vote or to direct the vote of 4,476,393 shares of the Stock.

	(e)	(iii)	Jurika & Voyles, L.P. has the sole power to 
dispose or to direct the disposition of -0- shares of the Stock.

	(f)	(iv)	Jurika & Voyles, L.P. has the shared power to 
dispose or to direct the disposition of 4,892,224 shares of the 
Stock.

ITEM 5.  OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

If this statement is being filed to report the fact that as of 
the date hereof the reporting person has ceased to be the 
beneficial owner of more than five percent of the class of 
securities, check the following  /   /.

Instruction:  Dissolution of a group requires a response to this 
item.

ITEM 6.  OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER 
PERSO


SCHEDULE 13G
Page 5 of 5 Pages
CUSIP No. 58503X107

Jurika & Voyles, L.P. is a registered investment adviser whose 
clients have the right to receive or the power to direct the 
receipt of dividends from, or the proceeds from the sale of the 
Stock.  No individual client's holdings of the Stock are more 
than 5 percent of the class.

ITEM 7.  IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY 
WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT 
HOLDING COMPANY

Not applicable.

ITEM 8.  IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE 
GROUP

Not applicable.

ITEM 9.  NOTICE OF DISSOLUTION OF GROUP

Not Applicable.

ITEM 10.  CERTIFICATION

By signing below I certify that, to the best of my knowledge and 
belief, the securities referred to above were acquired in the 
ordinary course of business and were not acquired for the purpose 
of and do not have the effect of changing or influencing the 
control of the issuer of such securities and were not acquired in 
connection with or as a participant in any transaction having 
such purposes or effect.

SIGNATURES

After reasonable inquiry and to the best of my knowledge, I 
certify that the information set forth in this statement is true, 
complete and correct.

DATED:  March 12, 1997

Jurika & Voyles, L.P.


By:  ______________________________

        Glenn C. Voyles, Chairman